147 related articles for article (PubMed ID: 7745027)
1. Purine-binding factor (nm23) gene expression in pituitary tumors: marker of adenoma invasiveness.
Takino H; Herman V; Weiss M; Melmed S
J Clin Endocrinol Metab; 1995 May; 80(5):1733-8. PubMed ID: 7745027
[TBL] [Abstract][Full Text] [Related]
2. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
3. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract.
Cheng HL; Tong YC; Tzai TS; Weng CL; Ho CL; Yang WH; Lin JS; Chow NH
Oncol Rep; 2001; 8(1):193-6. PubMed ID: 11115597
[TBL] [Abstract][Full Text] [Related]
4. NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma.
Iizuka N; Oka M; Noma T; Nakazawa A; Hirose K; Suzuki T
Cancer Res; 1995 Feb; 55(3):652-7. PubMed ID: 7530600
[TBL] [Abstract][Full Text] [Related]
5. Genetic basis of pituitary adenoma invasiveness: a review.
Suhardja A; Kovacs K; Rutka J
J Neurooncol; 2001 May; 52(3):195-204. PubMed ID: 11519849
[TBL] [Abstract][Full Text] [Related]
6. NM23-H1 and NM23-H2 gene expression in human renal tumors.
Theisinger B; Engel M; Seifert M; Seitz G; Welter C
Anticancer Res; 1998; 18(2A):1185-9. PubMed ID: 9615786
[TBL] [Abstract][Full Text] [Related]
7. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.
Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M
Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979
[TBL] [Abstract][Full Text] [Related]
8. Identification of a second human nm23 gene, nm23-H2.
Stahl JA; Leone A; Rosengard AM; Porter L; King CR; Steeg PS
Cancer Res; 1991 Jan; 51(1):445-9. PubMed ID: 1988104
[TBL] [Abstract][Full Text] [Related]
9. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas.
Leone A; Seeger RC; Hong CM; Hu YY; Arboleda MJ; Brodeur GM; Stram D; Slamon DJ; Steeg PS
Oncogene; 1993 Apr; 8(4):855-65. PubMed ID: 8384356
[TBL] [Abstract][Full Text] [Related]
10. NM23 gene expression in human prostatic carcinomas and benign prostatic hyperplasias: altered expression in combined androgen blockaded carcinomas.
Borchers H; Meyers FJ; Gumerlock PH; Stewart SL; deVere White RW
J Urol; 1996 Jun; 155(6):2080-4. PubMed ID: 8618340
[TBL] [Abstract][Full Text] [Related]
11. Expression of nm23-H1 in human meningioma cells.
Wang SW; Yam HF; Yang L; Ng HK; Wang SL; Wu BQ; Wang ZH; Chew-Cheng SB; Chew EC
Anticancer Res; 1997; 17(5A):3569-73. PubMed ID: 9413204
[TBL] [Abstract][Full Text] [Related]
12. nm23-H1 gene expression in ovarian tumors--a potential tumor marker.
Kapitanovic S; Spaventi R; Vujsic S; Petrovic Z; Kurjak A; Pavelic ZP; Gluckman JL; Stambrook PJ; Pavelic K
Anticancer Res; 1995; 15(2):587-90. PubMed ID: 7763042
[TBL] [Abstract][Full Text] [Related]
13. Reduced nm 23-H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid.
Arai T; Watanabe M; Onodera M; Yamashita T; Masunaga A; Itoyama S; Itoh K; Sugawara I
Am J Pathol; 1993 Jun; 142(6):1938-44. PubMed ID: 8389529
[TBL] [Abstract][Full Text] [Related]
14. [Study on expression of nm23-H1 gene in laryngeal cancer tissues].
Wang Q; Guo M; Sun L
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(4):198-200. PubMed ID: 9642340
[TBL] [Abstract][Full Text] [Related]
15. Expression of nm23 antimetastatic gene product in parathyroid hyperplasia, adenoma and carcinoma. An immunohistological assessment.
Al-Maghrabi JA; Asa SL
Saudi Med J; 2005 May; 26(5):728-31. PubMed ID: 15951858
[TBL] [Abstract][Full Text] [Related]
16. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
Brenner AS; Thebo JS; Senagore AJ; Duepree HJ; Gramlich T; Ormsby A; Lavery IC; Fazio VW
Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of the nm23 gene products in testicular seminoma.
Hori K; Uematsu K; Yasoshima H; Sakurai K; Yamada A; Ohya M
Pathol Int; 1997 May; 47(5):288-92. PubMed ID: 9143023
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of nm23-H1 in stage I non-small cell lung cancer: a useful marker in prediction of metastases.
Lai WW; Wu MH; Yan JJ; Chen FF
Ann Thorac Surg; 1996 Nov; 62(5):1500-4. PubMed ID: 8893591
[TBL] [Abstract][Full Text] [Related]
19. The role of nm23-H1 in the progression of transitional cell bladder cancer.
Chow NH; Liu HS; Chan SH
Clin Cancer Res; 2000 Sep; 6(9):3595-9. PubMed ID: 10999750
[TBL] [Abstract][Full Text] [Related]
20. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker.
Bates AS; Farrell WE; Bicknell EJ; McNicol AM; Talbot AJ; Broome JC; Perrett CW; Thakker RV; Clayton RN
J Clin Endocrinol Metab; 1997 Mar; 82(3):818-24. PubMed ID: 9062489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
